These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729 [TBL] [Abstract][Full Text] [Related]
4. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780 [TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice. Yao Y; Slosberg ED; Wang L; Hibshoosh H; Zhang YJ; Xing WQ; Santella RM; Weinstein IB Oncogene; 1999 Sep; 18(37):5159-66. PubMed ID: 10498865 [TBL] [Abstract][Full Text] [Related]
6. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT; Leder P Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037 [TBL] [Abstract][Full Text] [Related]
8. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461 [TBL] [Abstract][Full Text] [Related]
9. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420 [TBL] [Abstract][Full Text] [Related]
10. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
12. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation. Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141 [TBL] [Abstract][Full Text] [Related]
13. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254 [TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Delcommenne M; Tan C; Gray V; Rue L; Woodgett J; Dedhar S Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11211-6. PubMed ID: 9736715 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cordes N Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908 [TBL] [Abstract][Full Text] [Related]
16. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980 [TBL] [Abstract][Full Text] [Related]
17. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Mi Z; Guo H; Wai PY; Gao C; Kuo PC Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180 [TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
20. The role of integrin-linked kinase (ILK) in cancer progression. Persad S; Dedhar S Cancer Metastasis Rev; 2003 Dec; 22(4):375-84. PubMed ID: 12884912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]